Printer Friendly
The Free Library
14,588,681 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Expression Analysis Adopts NuGEN's Ovation(TM) System for Small-Sample Amplification.


DURHAM, N.C. -- Expression Analysis, Inc., the industry's leading provider of Affymetrix GeneChip[R] brand microarray See micro array.

microarray - A technique for performing many DNA experiments in parallel. Nothing to do with computers.
 services for clinical trials, announced today that it has adopted NuGEN Technologies' Ovation[TM] System family of products for amplification, fragmentation and labeling of samples with limited quantities of total RNA RNA: see nucleic acid.
RNA
 in full ribonucleic acid

One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic
 for GeneChip microarray analysis.

"Our validation of the Ovation[TM] System utilized the same RNA samples tested in the Microarray Quality Control Project and employed many of the same analysis methods. Our assessment indicated that the data was excellent and superior in quality relative to that generated using two cycles of in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment.

in vi·tro
adj.
In an artificial environment outside a living organism.
 transcription," commented Dr. Tom Goralski, Senior Director of Laboratory Operations at Expression Analysis. "We hope to migrate all of our clients who require microarray testing with limited RNA specimens to this service. We will continue to evaluate the Ovation[TM] System for potential use with whole blood samples."

Expression Analysis, Inc. also announced that it will begin to validate the new WT-Ovation[TM] Pico RNA Amplification System amplification system Physiology A generic term for any group of proteins that function in coordinated sequences, forming positive feedback loops for expanding the response to a low intensity signal
Amplification systems
Coagulation,
 for ultra-small and/or degraded de·grad·ed  
adj.
1. Reduced in rank, dignity, or esteem.

2. Having been corrupted or depraved.

3. Having been reduced in quality or value.
 specimens in early October. "We believe this product may be extremely useful in tumor-based oncology applications," continued Dr. Goralski.

"Adoption of the Ovation[TM] platform by Expression Analysis speaks to the value of NuGEN's technology for laboratories involved in high throughput work with valuable and limited samples, especially in the area of oncology research," said Dr. Sue Pandey, Vice President of Commercial Operations at NuGEN Technologies. "We are extremely pleased to be working with Expression Analysis."

About Expression Analysis, Inc.

Expression Analysis, Inc. (http://www.expressionanalysis.com) is the industry's leading provider of Affymetrix GeneChip[R]: brand microarray services for clinical trials. Specializing in gene expression, genotyping Genotyping refers to the process of determining the genotype of an individual with a biological assay. Current methods of doing this include PCR, DNA sequencing, and hybridization to DNA microarrays or beads.  and resequencing, the Company became the first GLP See gateway location protocol.  compliant microarray processing laboratory in the world. The Company provides start to finish microarray contract testing offering high throughput, high quality and cost-effective results in a regulatory compliant environment to advance genomic science.

About NuGEN Technologies Inc.

NuGEN Technologies, based in San Carlos San Carlos (săn kär`lōs), residential city (1990 pop. 26,167), San Mateo co., W Calif.; inc. 1925. The chief manufactures are plastic products, hardware, and machine parts. , CA, is focused on the development and commercialization of sensitive, rapid and high-throughput amplification and detection systems to enable the comprehensive analysis and discovery of biological mechanisms, cellular responses, and disease pathologies. For more information, visit www.nugeninc.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 26, 2006
Words:369
Previous Article:NeoGuide Systems Closes Series C Financing.
Next Article:Pharma Companies' Internet Marketing Spend to Increase Nearly 25% this Year to $780 million.



Related Articles
Rhinosporidium seeberi: A Human Pathogen from a Novel Group of Aquatic Protistan Parasites.(Statistical Data Included)
Progress in the Application of DNA Microarrays? (Reviews).
A competitive ELISA to detect brevetoxins from Karenia brevis (formerly Gymnodinium breve) in seawater, shellfish, and mammalian body fluid....
Survey for Sarcocystis Neurona in Taxa of Small Mammals from Johnson and Henry Counties, Missouri. (Biological Science Section).(Brief Article)
Use molecular tools to determine ability of probiotics to hinder pathogens.
Simplified sensor technology advances to commercialization.
Design of a microsphere-based high-throughput gene expression assay to determine estrogenic potential.(Research)
Nuclear small-subunit ribosomal RNA gene-based characterization, molecular phylogeny and PCR detection of the neoparamoeba from Western Long Island...
NuGEN Launches Two New Products: The WT-Ovation(TM) Pico RNA Amplification System and the FL-Ovation(TM) cDNA Biotin Module V2.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles